TY - JOUR
T1 - Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis
AU - Anzai, Atsushi
AU - Mindur, John E.
AU - Halle, Lennard
AU - Sano, Soichi
AU - Choi, Jennifer L.
AU - He, Shun
AU - McAlpine, Cameron S.
AU - Chan, Christopher T.
AU - Kahles, Florian
AU - Valet, Colin
AU - Fenn, Ashley M.
AU - Nairz, Manfred
AU - Rattik, Sara
AU - Iwamoto, Yoshiko
AU - Fairweather, De Lisa
AU - Walsh, Kenneth
AU - Libby, Peter
AU - Nahrendorf, Matthias
AU - Swirski, Filip K.
N1 - Funding Information:
This work was supported in part by the National Institutes of Health (grants R35 HL135752, R01 HL128264, and P01 HL131478); the American Heart Association’s Established Investigator Award; and the Patricia and Scott Eston MGH Research Scholar Award (to F.K. Swirski). A. Anzai was supported by grants from the Uehara Memorial Foundation, the Kanae Foundation for the Promotion of Medical Science, and the Japan Society for the Promotion of Science (KAKENHI grant 18K08048). L. Halle was supported by a Boehringer-Ingelheim Fonds MD fellowship. S. Sano was supported by an American Heart Association post- doctoral fellowship. C.S. McAlpine was supported by Canadian Institutes of Health Research and Banting Research Foundation postdoctoral awards. C. Valet was supported by a Fondation pour la Recherche Medicale postdoctoral fellowship. D. Fairweather was supported by the National Institutes of Health (grant R01 HL111938). K. Walsh was supported by the National Institutes of Health (grant R01 HL131006). The authors declare no competing financial interests.
Publisher Copyright:
© 2019 Anzai et al.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Acquisition of self-reactive effector CD4+ T cells is a major component of the autoimmune response that can occur during myocarditis, an inflammatory form of cardiomyopathy. Although the processes by which self-reactive T cells gain effector function have received considerable attention, how these T cells contribute to effector organ inflammation and damage is less clear. Here, we identified an IL-3–dependent amplification loop that exacerbates autoimmune inflammation. In experimental myocarditis, we show that effector organ–accumulating autoreactive IL-3+ CD4+ T cells stimulate IL-3R+ tissue macrophages to produce monocyte-attracting chemokines. The newly recruited monocytes differentiate into antigen-presenting cells that stimulate local IL-3+ CD4+ T cell proliferation, thereby amplifying organ inflammation. Consequently, Il3−/− mice resist developing robust autoimmune inflammation and myocardial dysfunction, whereas therapeutic IL-3 targeting ameliorates disease. This study defines a mechanism that orchestrates inflammation in myocarditis, describes a previously unknown function for IL-3, and identifies IL-3 as a potential therapeutic target in patients with myocarditis.
AB - Acquisition of self-reactive effector CD4+ T cells is a major component of the autoimmune response that can occur during myocarditis, an inflammatory form of cardiomyopathy. Although the processes by which self-reactive T cells gain effector function have received considerable attention, how these T cells contribute to effector organ inflammation and damage is less clear. Here, we identified an IL-3–dependent amplification loop that exacerbates autoimmune inflammation. In experimental myocarditis, we show that effector organ–accumulating autoreactive IL-3+ CD4+ T cells stimulate IL-3R+ tissue macrophages to produce monocyte-attracting chemokines. The newly recruited monocytes differentiate into antigen-presenting cells that stimulate local IL-3+ CD4+ T cell proliferation, thereby amplifying organ inflammation. Consequently, Il3−/− mice resist developing robust autoimmune inflammation and myocardial dysfunction, whereas therapeutic IL-3 targeting ameliorates disease. This study defines a mechanism that orchestrates inflammation in myocarditis, describes a previously unknown function for IL-3, and identifies IL-3 as a potential therapeutic target in patients with myocarditis.
UR - http://www.scopus.com/inward/record.url?scp=85061143073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061143073&partnerID=8YFLogxK
U2 - 10.1084/jem.20180722
DO - 10.1084/jem.20180722
M3 - Article
C2 - 30670465
AN - SCOPUS:85061143073
SN - 0022-1007
VL - 216
SP - 369
EP - 383
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 2
ER -